<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0009563'>Dyskeratosis</z:mp> congenita is a rare inherited <z:hpo ids='HP_0005528'>bone marrow failure</z:hpo> characterized by excessively short telomeres in highly proliferative tissues </plain></SENT>
<SENT sid="1" pm="."><plain>These abnormalities are due to disturbance of the telomere maintenance machinery </plain></SENT>
<SENT sid="2" pm="."><plain>The clinical presentation is characterized by skin <z:hpo ids='HP_0001000'>pigmentation</z:hpo>, <z:hpo ids='HP_0008404'>nail dystrophy</z:hpo>, and mucosal <z:e sem="disease" ids="C0023531" disease_type="Neoplastic Process" abbrv="">leukoplakia</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> these mucocutaneous features are rare in childhood: they usually appear between 5 and 10 years of age </plain></SENT>
<SENT sid="4" pm="."><plain>In young children, the initial presentation can associate <z:hpo ids='HP_0005528'>bone marrow failure</z:hpo> and neurological or ocular problems: Hoyeraal-Hreidarsson and <z:e sem="disease" ids="C1327916" disease_type="Disease or Syndrome" abbrv="">Revesz syndromes</z:e>, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>Clinical progression of the disease can lead to <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (86% of <z:hpo ids='HP_0000001'>all</z:hpo> patients) and to pulmonary or hepatic complications </plain></SENT>
<SENT sid="6" pm="."><plain>These patients also have an increased risk of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Diagnosis is often suspected on <z:hpo ids='HP_0005528'>bone marrow failure</z:hpo> with no clinical or biological abnormalities compatible with Fanconi <z:hpo ids='HP_0001903'>anemia</z:hpo> diagnosis </plain></SENT>
<SENT sid="8" pm="."><plain>The telomere length study can be helpful for diagnosis in case of <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> in children before studying gene mutations </plain></SENT>
<SENT sid="9" pm="."><plain>Until now, 6 genes (DKC1, TERT, TERC, NOLA2, NOLA3, TINF2) have been identified in <z:mp ids='MP_0009563'>dyskeratosis</z:mp> congenita </plain></SENT>
<SENT sid="10" pm="."><plain>Transmission of the disease can be <z:hpo ids='HP_0000007'>autosomal recessive</z:hpo>, <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo>, or <z:hpo ids='HP_0001417'>X-linked</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>In half of the cases, the genetic abnormality is unknown </plain></SENT>
<SENT sid="12" pm="."><plain>Treatment of DC has to be adapted to each patient, from symptomatic or androgenic treatment to hematopoietic stem cell transplantation </plain></SENT>
</text></document>